Medicare Enrolled

Dr. Samuel Apeatu, MD

Neurodevelopmental Disabilities Physician · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
225 BROADWAY STE 705, New York, NY 10007
2123492787
In practice since 2006 (19 years)
NPI: 1013939545 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Apeatu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Apeatu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Apeatu

Dr. Samuel Apeatu is a neurodevelopmental disabilities physician in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Apeatu performed 287 Medicare services across 271 unique beneficiaries.

Between the years covered by Open Payments, Dr. Apeatu received a total of $2,008 from 25 pharmaceutical and/or device companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurodevelopmental disabilities physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Apeatu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 287 Medicare services $2,008 industry payments

Medicare Practice Summary

Medicare Utilization ↗
287
Medicare services
1.0× state median for neurodevelopmental disabilities physician
271
Unique beneficiaries
$226
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Complete ultrasound of brain blood flow
An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation.
 57 $200 $484
Ultrasound of brain blood flow following medication
An ultrasound test used to assess blood flow within the brain after a medication has been administered.
 57 $258 $497
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
 55 $179 $541
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
 45 $357 $684
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 37 $73 $159
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
 22 $421 $794
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
 14 $62 $116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
82.2% medium
12.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,008
Total received (2020-2024)
Avg $402/year across 5 years
Top 50% in NY for neurodevelopmental disabilities physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
95
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,008 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$824
2023
$184
2022
$397
2021
$544
2020
$59

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$428
Corium, LLC
$78
Eisai Inc.
$62
ABBVIE INC.
$52
Neurocrine Biosciences, Inc.
$46
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Amneal Pharmaceuticals LLC
$28
Lundbeck LLC
$28
Neurelis, Inc.
$27
TG Therapeutics, Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
Top 3 companies account for 69.0% of 2024 payments
All-time payments by company (2020-2024) ›
Supernus Pharmaceuticals, Inc.
$463
Neurelis, Inc.
$229
Biohaven Pharmaceutical Holding Company Ltd.
$184
SK Life Science, Inc.
$147
Allergan, Inc.
$145
Teva Pharmaceuticals USA, Inc.
$102
UCB, Inc.
$89
Neurocrine Biosciences, Inc.
$81
Corium, LLC
$78
Eisai Inc.
$62
ABBVIE INC.
$52
Lundbeck LLC
$51
EISAI INC.
$47
Arbor Pharmaceuticals, Inc.
$33
ACADIA Pharmaceuticals Inc
$31
AbbVie Inc.
$29
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Amneal Pharmaceuticals LLC
$28
TG Therapeutics, Inc.
$24
Lilly USA, LLC
$23
BioMarin Pharmaceutical Inc.
$19
HARMONY BIOSCIENCES LLC
$17
JAZZ PHARMACEUTICALS INC.
$15
Greenwich Biosciences, Inc.
$14
Biogen, Inc.
$14
Top 3 companies account for 43.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · AUSTEDO · Austedo XR · Azstarys · BOTOX · BRIUMVI · Briviact · DAYBUE · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · Horizant · INGREZZA · Leqembi · NURTEC ODT · ONGENTYS · QELBREE · QULIPTA · Qelbree · RADICAVA · RYTARY · UBRELVY · VALTOCO · VYEPTI · Vimizim · Wakix · XCOPRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurodevelopmental disabilities physician in New York?
Compare neurodevelopmental disabilities physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse neurodevelopmental disabilities physicians nearby

Geographic Context

Neurodevelopmental disabilities physicians within 10 mi
4
Per 100K population
0.2
County median income
$104,553
Nearest hospital
NY EYE AND EAR INFIRMARY OF MOUNT SINAI
1.6 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Apeatu is a mixed practice specialist, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Apeatu experienced with complete ultrasound of brain blood flow?
Based on Medicare claims data, Dr. Apeatu performed 57 complete ultrasound of brain blood flow services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Apeatu receive payments from pharmaceutical companies?
Yes. Dr. Apeatu received a total of $2,008 from 25 companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Apeatu's costs compare to other neurodevelopmental disabilities physicians in New York?
Dr. Apeatu's average Medicare payment per service is $226. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Apeatu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Neurodevelopmental Disabilities Physicians in New York
Browse neurodevelopmental disabilities physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Neurodevelopmental Disabilities Physicians in NY
Neurodevelopmental disabilities physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurodevelopmental Disabilities Physicians in NY
Which NY neurodevelopmental disabilities physicians receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Neurelis, Inc. Payments to Doctors
See all physicians who received payments from Neurelis, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →